A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

Clinical trial NCT05955508 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT05955508

Sponsor

Regeneron Pharmaceuticals

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2024-01-30

Primary completion

2033-01-25

Enrollment

40

View on ClinicalTrials.gov